Company intelligence / Profile preview

Tri.O Medical

Ma'alot-Tarshiha, Northern District, Israellinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Tri.O Medical has developed FITT, an innovative wearable medical device that treats diabetic foot ulcers using three methods—compression therapy to evacuate edema, negative pressure to increase blood flow, and ozone disinfection. The solution aims to reduce amputations and improve quality of life for diabetes patients. Clinical results are not detailed publicly but the product is positioned as a significant breakthrough in DFU care.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Tri.O Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tri.O Medical.

Explore the full profile